Abridge is launching its first product built specifically for the mid-revenue cycle.
The San Francisco-based AI-native clinician intelligence platform is adding a pre-bill review capability built for clinical documentation integrity, coding and revenue cycle teams, according to a Sept. 14 news release.
The capability compares final coded diagnoses and diagnosis related group against what the clinical documentation supports, flagging discrepancies with supporting evidence before claims go out, according to the release. Because Abridge captures records during the original clinical encounter, CDI and coding teams can review claims using the same context clinicians relied on, rather than reconstructing details from a signed chart weeks after discharge. Abridge does not alter documentation, codes or claim status; CDI teams retain control over what to hold, correct or release.
“Health systems aren’t reimbursed for the care that they deliver. They’re reimbursed for the care they document that they delivered,” Abridge Co-founder and CEO Shiv Rao, MD, said in the release.
Founded in 2018, Abridge said its platform will support more than 100 million patient-clinician conversations across more than 300 health systems this year.
